Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 298

Sort by

Sort Order Select

Journal Articles

Real-world response and toxicity profiles of sequential bispecific antibody therapies in Relapsed/Refractory multiple myeloma

Agrima Mian, Rafaella Ferreira De Araujo Litvin, Kelsey Pandrangi, Kristina Nasr, Sharan Jhaveri, Mikhaila Rice, Joslyn Rudoni, Louis Williams, Christy Samaras, John Molina, Betty K. Hamilton, Shahzad Raza, Faiz Anwer, Jason Valent, Claudio Brunstein, Brian Hill, Paolo Caimi, Sandra Mazzoni

Blood (2025) 146 (Supplement 1): 6376.

https://doi.org/10.1182/blood-2025-6376

Published: 2025

Journal Articles

Safety and efficacy of BCMA directed CAR-T therapy in older patients (Aged ≥ 75) with relapsed or refractory multiple myeloma (RRMM)

Blood (2025) 146 (Supplement 1): 6375.

https://doi.org/10.1182/blood-2025-6375

Published: 2025

Journal Articles

Real-world outcomes with teclistamab in relapsed/refractory multiple myeloma and severe renal failure: A propensity matched multi-center retrospective study using trinetx database

Deevyashali Parekh, Beth Faiman, Sandra Mazzoni, Louis Williams, Jack Khouri, Hossam M. Ali, Utkarsh Goel, Jason Valent, Diana Basali, Christy Samaras, Tara Roy, Alexandra McDonald, Faiz Anwer, Majid Jaberi, Kirti Arora, Haleema Sadia Adil, Julie Bevacqua, Rahul Seth, Shahzad Raza

Blood (2025) 146 (Supplement 1): 6372.

https://doi.org/10.1182/blood-2025-6372

Published: 2025

Journal Articles

Real-world utilization patterns of bone-modifying agents for multiple myeloma in the era of novel therapies

Hamlet Gasoyan, Michael Rothberg, Jeffrey Kovach, Nicholas Casacchia, Hossam M. Ali, Yara Shatnawi, Brittany Peterre, Ming Wang, Jason Valent, Faiz Anwer

Blood (2025) 146 (Supplement 1): 4402.

https://doi.org/10.1182/blood-2025-4402

Published: 2025

Journal Articles

Risk of cardiovascular disease-related mortality in hematologic malignancy patients: A population-level US retrospective cohort study, 1975-2022

Husayn Ladha, Hetty Carraway, Aaron Gerds, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Faiz Anwer, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 4497.

https://doi.org/10.1182/blood-2025-4497

Published: 2025

Journal Articles

Real-time interleukin-6 (IL-6) kinetics predict cytokine release syndrome (CRS) in patients receiving chimeric antigen receptor (CAR) T-cell therapy for Relapsed/Refractory B-cell malignancies

Agrima Mian, Rafaella Ferreira De Araujo Litvin, Jessica Colon-Franco, Sujata Patil, Megan Molnar, Allison Winter, Sandra Mazzoni, Robert Dean, Louis Williams, Aaron Gerds, John Molina, Shahzad Raza, Faiz Anwer, Deepa Jagadeesh, Betty K. Hamilton, Claudio Brunstein, Brian Hill, Paolo Caimi

Blood (2025) 146 (Supplement 1): 2397.

https://doi.org/10.1182/blood-2025-2397

Published: 2025

Journal Articles

Talquetamab outcomes in relapsed/refractory myeloma with extramedullary and paraskeletal soft tissue plasmacytomas

Blood (2025) 146 (Supplement 1): 825.

https://doi.org/10.1182/blood-2025-825

Published: 2025

Journal Articles

Dysregulated proteasome proteostasis acts as a driver of light chain amyloidosis

Sandra Mazzoni, Babal Jha, Louis Williams, Jack Khouri, Christy Samaras, Shahzad Raza, Faiz Anwer, Jason Valent, Arda Durmaz, Yahan Zhang, Kacey O'Donnell

Blood (2025) 146 (Supplement 1): 7473.

https://doi.org/10.1182/blood-2025-7473

Published: 2025

Journal Articles

Subsequent primary malignancies after CAR-T therapy: A study from the US multiple myeloma immunotherapy consortium

Blood (2025) 146 (Supplement 1): 5852.

https://doi.org/10.1182/blood-2025-5852

Published: 2025

Journal Articles

Prognostic factors and survival outcomes of urgent inpatient chemotherapy for relapsed/refractory lymphoma in the modern era

Abhishek Kataria, Mikhaila Rice, Wei Wei, Faiz Anwer, Paolo Caimi, Allison Winter, Robert Dean, Taylor Brooks, Joslyn Rudoni, Jack Khouri, Christy Samaras, Shahzad Raza, Sandra Mazzoni, Jason Valent, Brian Hill, Deepa Jagadeesh

Blood (2025) 146 (Supplement 1): 2737.

https://doi.org/10.1182/blood-2025-2737

Published: 2025

Journal Articles

Patients with multiple myeloma and CKD: Should we really hold off on bispecific therapy in this subgroup?

Kirti Arora, Rishi Chowdhary, Diana Basali, Christy Samaras, Akriti Jain, Deevyashali Parekh, Jason Valent, Jack Khouri, Louis Williams, Sandra Mazzoni, Abhay Singh, Faiz Anwer, Shahzad Raza

Blood (2025) 146 (Supplement 1): 2248.

https://doi.org/10.1182/blood-2025-2248

Published: 2025

Journal Articles

Predictors of early relapse following ciltacabtagene autoleucel: Informing risk-adapted therapy in relapsed/refractory multiple myeloma

Doris Hansen, Lauren Peres, Danai Dima, Saurabh Zanwar, Omar Alexis Castaneda Puglianini, Alicia Richards, Mahmoud Gaballa, Oren Pasvolsky, Aimaz Afrough, Brett Reid, Ariel Grajales-Cruz, Zhuoer Xie, Utkarsh Goel, Aishwarya Sannareddy, Christen Dillard, Christopher Ferreri, Shebli Atrash, Cindy Varga, Andrew Portuguese, Hitomi Hosoya, Lekha Mikkilineni, Nilesh Kalariya, Damian Mikulski, Charlotte Wagner, Christopher Cahoon, Peter Cheng, Christian Gordillo, Eli Zolotov, Evguenia Bhurtel, Jeries Kort, Raffaella Cassano Cassano, Shonali Midha, James Davis, Rebecca Gonzalez, Megan Herr, Hamza Hassan, Sneha Purvey, Marcus Geer, Kimberly Green, Fabiana Perna, Hien Liu, Taiga Nishihori, Jack Khouri, Shahzad Raza, Faiz Anwer, Susan Bal, Omar Nadeem, Ciara Louise Freeman, Rahul Banerjee, Leyla Shune, Ran Reshef, Kenneth Shain, Melissa Alsina, Rachid Baz, Douglas Sborov, Peter Voorhees, Larry Anderson, Luciano Costa, Noa Biran, Shaji Kumar, Frederick Locke, Yi Lin, Surbhi Sidana, Krina Patel

Blood (2025) 146 (Supplement 1): 93.

https://doi.org/10.1182/blood-2025-93

Published: 2025

Journal Articles

Aberrant clonal plasma cells bypass the proteasome proteostasis by endoplasmic reticulum associated protein degradation

Yahan Zhang, Sandra Mazzoni, Arda Durmaz, Kacey O'Donnell, Christy Samaras, Faiz Anwer, Shahzad Raza, Jason Valent, Jack Khouri, Louis Williams, Babal Jha

Blood (2025) 146 (Supplement 1): 7476.

https://doi.org/10.1182/blood-2025-7476

Published: 2025

Journal Articles

Enhancing the safety of ciltacabtagene autoleucel in relapsed multiple myeloma (MM): Identification of potentially modifiable risk-factors associated with delayed neurotoxicity and non-relapse mortality

Surbhi Sidana, Brett Reid, Danai Dima, Lauren Peres, Mahmoud Gaballa, Rahul Banerjee, Oren Pasvolsky, Aimaz Afrough, Christen Dillard, Christopher Ferreri, Shebli Atrash, Cindy Varga, Andrew Portuguese, Masooma Rana, Hitomi Hosoya, Lekha Mikkilineni, Vanna Hovanky, Saurabh Zanwar, Nilesh Kalariya, Damian Mikulski, Charlotte Wagner, Christopher Cahoon, Omar Alexis Castaneda Puglianini, Gabriel De Avila, Christian Gordillo, Eli Zolotov, Ariel Grajales-Cruz, Utkarsh Goel, Aishwarya Sannareddy, Jeries Kort, Raffaella Cassano, Shonali Midha, James Davis, Rebecca Gonzalez, Megan Herr, Zhuoer Xie, Hamza Hassan, Sneha Purvey, Marcus Geer, Kimberly Green, Fabiana Perna, Hien Liu, Taiga Nishihori, Jack Khouri, Shahzad Raza, Faiz Anwer, Susan Bal, Omar Nadeem, Ciara Louise Freeman, Leyla Shune, Ran Reshef, Kenneth Shain, Melissa Alsina, Rachid Baz, Douglas Sborov, Saurabh Dahiya, Frederick Locke, David Miklos, Peter Voorhees, Larry Anderson, Luciano Costa, Noa Biran, Shaji Kumar, Yi Lin, Krina Patel, Doris Hansen

Blood (2025) 146 (Supplement 1): 1034.

https://doi.org/10.1182/blood-2025-1034

Published: 2025

Journal Articles

Unwinding the genomic threads of monoclonal gammopathy of renal significance through ultra-low pass whole genome sequencing

Blood (2025) 146 (Supplement 1): 3970.

https://doi.org/10.1182/blood-2025-3970

Published: 2025

Journal Articles

Fat pad biopsy versus target organ biopsy in systemic AL amyloidosis detection

Kristina Nasr, Yan Zou, Shahzad Raza, Mazen Hanna, Jack Khouri, Jason Valent, Christy Samaras, Sandra Mazzoni, Cynthia Scott, Kimberly Hamilton, Saveta Mathur, Beth Faiman, Louis Williams, Faiz Anwer, Diana Basali

Blood (2025) 146 (Supplement 1): 3969.

https://doi.org/10.1182/blood-2025-3969

Published: 2025

Journal Articles

Real-world safety and efficacy of BCMA bispecific antibodies in relapsed light chain amyloidosis

Vasil Mico, Raymond Comenzo, Shahzad Raza, Jason Valent, Faiz Anwer, Christy Samaras, Louis Williams, Jack Khouri, Xia Wu, Parva Bhatt, Andreas Klein, Joslyn Rudoni, Teresa Fogaren, Mikhaila Rice, Jonathan Kissam, Sandra Mazzoni

Blood (2025) 146 (Supplement 1): 3961.

https://doi.org/10.1182/blood-2025-3961

Published: 2025

Journal Articles

Pulmonary complications in acute myelogenous leukemia in post allogenic hematopoietic stem cell transplant period and yield of bronchoalveolar lavage and biopsy- single center experience

Aneela Majeed, Eric Cober, Simon Mucha, Faiz Anwer, Zachary Yetmar

Blood (2025) 146 (Supplement 1): 3381.

https://doi.org/10.1182/blood-2025-3381

Published: 2025

Journal Articles

Major adverse cardiovascular events (MACE) in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: A target trial emulation study

Omer Ashruf, Henyah Dardir, Ankit Patel, Emily Moncher, Nandhini Ravichandran, David Kaelber, Sophia Balderman, Anjali Advani, John Molina, Moaath Mustafa Ali, Aaron Gerds, Hetty Carraway, Faiz Anwer, Abhay Singh, Sudipto Mukherjee, Larry Cripe, Akriti Jain

Blood (2025) 146 (Supplement 1): 4627.

https://doi.org/10.1182/blood-2025-4627

Published: 2025

Journal Articles

Outcomes of urgent inpatient chemotherapy for relapsed/refractory multiple myeloma in the modern era

Blood (2025) 146 (Supplement 1): 4601.

https://doi.org/10.1182/blood-2025-4601

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Real-world response and toxicity profiles of sequential bispecific antibody therapies in Relapsed/Refractory multiple myeloma

Safety and efficacy of BCMA directed CAR-T therapy in older patients (Aged ≥ 75) with relapsed or refractory multiple myeloma (RRMM)

Real-world outcomes with teclistamab in relapsed/refractory multiple myeloma and severe renal failure: A propensity matched multi-center retrospective study using trinetx database

Real-world utilization patterns of bone-modifying agents for multiple myeloma in the era of novel therapies

Risk of cardiovascular disease-related mortality in hematologic malignancy patients: A population-level US retrospective cohort study, 1975-2022

Real-time interleukin-6 (IL-6) kinetics predict cytokine release syndrome (CRS) in patients receiving chimeric antigen receptor (CAR) T-cell therapy for Relapsed/Refractory B-cell malignancies

Talquetamab outcomes in relapsed/refractory myeloma with extramedullary and paraskeletal soft tissue plasmacytomas

Dysregulated proteasome proteostasis acts as a driver of light chain amyloidosis

Subsequent primary malignancies after CAR-T therapy: A study from the US multiple myeloma immunotherapy consortium

Prognostic factors and survival outcomes of urgent inpatient chemotherapy for relapsed/refractory lymphoma in the modern era

Patients with multiple myeloma and CKD: Should we really hold off on bispecific therapy in this subgroup?

Predictors of early relapse following ciltacabtagene autoleucel: Informing risk-adapted therapy in relapsed/refractory multiple myeloma

Aberrant clonal plasma cells bypass the proteasome proteostasis by endoplasmic reticulum associated protein degradation

Enhancing the safety of ciltacabtagene autoleucel in relapsed multiple myeloma (MM): Identification of potentially modifiable risk-factors associated with delayed neurotoxicity and non-relapse mortality

Unwinding the genomic threads of monoclonal gammopathy of renal significance through ultra-low pass whole genome sequencing

Fat pad biopsy versus target organ biopsy in systemic AL amyloidosis detection

Real-world safety and efficacy of BCMA bispecific antibodies in relapsed light chain amyloidosis

Pulmonary complications in acute myelogenous leukemia in post allogenic hematopoietic stem cell transplant period and yield of bronchoalveolar lavage and biopsy- single center experience

Major adverse cardiovascular events (MACE) in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: A target trial emulation study

Outcomes of urgent inpatient chemotherapy for relapsed/refractory multiple myeloma in the modern era

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only